Efficacy and tolerability of linezolid in the treatment of MDR-TB cases: a TBNET study in Germany and Italy Source: Annual Congress 2008 - Multidrug-resistant and the emerging threat of extensively drug-resistant tuberculosis Year: 2008
Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK Source: Eur Respir J, 55 (6) 1902363; 10.1183/13993003.02363-2019 Year: 2020
Clinical outcome in patients treated with omalizumab during pre-approval period in France Source: Eur Respir J 2007; 30: Suppl. 51, 621s Year: 2007
Eligibility for mepolizumab, omalizumab and reslizumab in the EU population: The IDEAL study Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016
Guidelines improved asthma treatment in Gunma, Japan Source: Eur Respir J 2003; 22: Suppl. 45, 258s Year: 2003
Real-world treatment of incident COPD patients in Germany Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
Prescription of antitussives in asthma: A cross-sectional study in primary care in France and in Italy Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012
Cost-effectiveness of budesonide/formoterol added to tiotropium in COPD patients in Canada, Australia and Sweden Source: Annual Congress 2010 - Does cost-effectiveness go together with best quality of treatment? New drivers in medicine Year: 2010
Efficacy and safety of nivolumab in routine NSCLC treatment – an observational study in 5 lung cancer centers in Berlin, Germany Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017
Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018 Year: 2019
Cost-effectiveness of treating MDR-TB by adding delamanid to background regimens in Germany Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Evaluation of COPD treatment success by office-based pneumologists in Germany using the example of tiotropium Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care Year: 2011
Cost-effectiveness of incorporating bedaquiline into a treatment regimen for MDR/XDR-TB in Germany Source: Eur Respir J 2015; 46: 1826-1829 Year: 2015
The current treatment of asthma in Italy Source: Eur Respir J 2002; 20: Suppl. 38, 427s Year: 2002
The DACCORD study: Real-life COPD outpatient treatment with long-acting bronchodilators in Germany Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013
Drug therapy of childhood asthma: results of a community-based survey in Germany Source: Eur Respir J 2001; 18: Suppl. 33, 121s Year: 2001
Are SABA-reliant asthma patients receiving adequate ICS therapy? A nationwide cohort study in Sweden (HERA) Source: International Congress 2019 – Asthma treatment: novel insights from clinical studies Year: 2019
Targeted literature review: epidemiology of severe and uncontrolled asthma and associated biomarkers in France, Germany, Italy, Spain and the UK Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020
Long-term follow-up of patients under omalizumab initiated during the pre-approval period in France Source: Annual Congress 2010 - Management of airway disease Year: 2010
Cost-of-illness of COPD in Germany Source: Eur Respir J 2003; 22: Suppl. 45, 376s Year: 2003